Cytokinetics Inc. buy BiotechBee
Start price
07.09.22
/
70%
€50.50
Target price
31.12.24
€80.00
Performance (%)
-29.90%
End price
05.05.23
€35.40
Summary
This prediction ended on 05.05.23 with a price of €35.40. The prediction for Cytokinetics Inc. disappointed with a performance of -29.90%. BiotechBee has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cytokinetics Inc. | 10.638% | 10.638% | 98.473% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to BiotechBee what are the pros and cons of Cytokinetics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cytokinetics Inc. diskutieren
Buy mit Kursziel 80,0
In the thread Trading Cytokinetics Inc.
Buy beendet
Current prediction by BiotechBee for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€66.50
07.04.24
07.04.24
€110.00
31.12.25
31.12.25
-24.81%
04.10.24
04.10.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
25.01.24
25.01.24
€110.00
31.03.26
31.03.26
-0.66%
02.02.24
02.02.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
24.12.23
24.12.23
€100.00
28.02.26
28.02.26
73.52%
25.01.24
25.01.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€32.80
10.12.23
10.12.23
€55.00
30.06.25
30.06.25
33.54%
24.12.23
24.12.23
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.60
02.12.23
02.12.23
€60.00
28.02.26
28.02.26
7.19%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year